142 related articles for article (PubMed ID: 37552416)
1. Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018-2040.
Ortega-Ortega M; Hanly P; Pearce A; Soerjomataram I; Sharp L
Appl Health Econ Health Policy; 2023 Nov; 21(6):877-889. PubMed ID: 37552416
[TBL] [Abstract][Full Text] [Related]
2. Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe.
Hanly P; Soerjomataram I; Sharp L
Int J Cancer; 2015 Feb; 136(4):E136-45. PubMed ID: 25066804
[TBL] [Abstract][Full Text] [Related]
3. The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study.
Hanly P; Ahern M; Sharp L; Ursul D; Loughnane G
Eur J Health Econ; 2022 Mar; 23(2):249-259. PubMed ID: 34417904
[TBL] [Abstract][Full Text] [Related]
4. The cost of premature death from cancer attributable to alcohol: Productivity losses in Europe in 2018.
Rumgay H; Ortega-Ortega M; Sharp L; Lunet N; Soerjomataram I
Cancer Epidemiol; 2023 Jun; 84():102365. PubMed ID: 37058915
[TBL] [Abstract][Full Text] [Related]
5. Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018.
Ortega-Ortega M; Hanly P; Pearce A; Soerjomataram I; Sharp L
Int J Cancer; 2022 Feb; 150(4):580-593. PubMed ID: 34569617
[TBL] [Abstract][Full Text] [Related]
6. The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden.
Hanly PA; Sharp L
BMC Cancer; 2014 Mar; 14():224. PubMed ID: 24670067
[TBL] [Abstract][Full Text] [Related]
7. Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach.
Hanly P; Ortega-Ortega M; Soerjomataram I
Curr Oncol; 2022 May; 29(5):3552-3564. PubMed ID: 35621677
[TBL] [Abstract][Full Text] [Related]
8. Productivity losses associated with premature mortality due to cancer in Russia: A population-wide study covering 2001-2030.
Barchuk A; Bespalov A; Huhtala H; Chimed T; Belyaev A; Moore M; Anttila A; Auvinen A; Pearce A; Soerjomataram I
Scand J Public Health; 2019 Jul; 47(5):482-491. PubMed ID: 31313982
[No Abstract] [Full Text] [Related]
9. Advances in the methodological approach to friction period estimation: A European perspective.
Hanly P; Ortega Ortega M; Pearce A; Soerjomataram I; Sharp L
Soc Sci Med; 2020 Nov; 264():113289. PubMed ID: 32836019
[TBL] [Abstract][Full Text] [Related]
10. Projecting productivity losses for cancer-related mortality 2011 - 2030.
Pearce A; Bradley C; Hanly P; O'Neill C; Thomas AA; Molcho M; Sharp L
BMC Cancer; 2016 Oct; 16(1):804. PubMed ID: 27756270
[TBL] [Abstract][Full Text] [Related]
11. Academic achievement and productivity losses associated with speech, language and communication needs.
Cronin P; Reeve R; McCabe P; Viney R; Goodall S
Int J Lang Commun Disord; 2020 Sep; 55(5):734-750. PubMed ID: 32687245
[TBL] [Abstract][Full Text] [Related]
12. The economic impact of cancer mortality among working-age individuals in Brazil from 2001 to 2030.
De Camargo Cancela M; Monteiro Dos Santos JE; Lopes de Souza LB; Martins LFL; Bezerra de Souza DL; Barchuk A; Hanly P; Sharp L; Soerjomataram I; Pearce A
Cancer Epidemiol; 2023 Oct; 86():102438. PubMed ID: 37579673
[TBL] [Abstract][Full Text] [Related]
13. Cost-of-illness of melanoma in Europe - a modelling approach.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33 Suppl 2():34-45. PubMed ID: 30811699
[TBL] [Abstract][Full Text] [Related]
14. [Change in productivity losses due to premature deaths in Spain: 2005-2009].
Peña Longobardo LM; Aranda-Reneo I; Oliva Moreno J; Vall Castello J
Rev Esp Salud Publica; 2015; 89(1):39-50. PubMed ID: 25946584
[TBL] [Abstract][Full Text] [Related]
15. The cost of lost productivity due to premature lung cancer-related mortality: results from Spain over a 10-year period.
Darbà J; Marsà A
BMC Cancer; 2019 Oct; 19(1):992. PubMed ID: 31646991
[TBL] [Abstract][Full Text] [Related]
16. Burden of Hodgkin and non-Hodgkin lymphoma in Spain over a 10-year period: productivity losses due to premature mortality.
Darbà J; Marsà A
Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):87-92. PubMed ID: 32450710
[No Abstract] [Full Text] [Related]
17. Economic burden of malignant blood disorders across Europe: a population-based cost analysis.
Burns R; Leal J; Sullivan R; Luengo-Fernandez R
Lancet Haematol; 2016 Aug; 3(8):e362-70. PubMed ID: 27476787
[TBL] [Abstract][Full Text] [Related]
18. The cost of cancer in Europe 2018.
Hofmarcher T; Lindgren P; Wilking N; Jönsson B
Eur J Cancer; 2020 Apr; 129():41-49. PubMed ID: 32120274
[TBL] [Abstract][Full Text] [Related]
19. The effect of hepatitis C-associated premature deaths on labour productivity losses in Spain: a ten-year analysis.
Peña-Longobardo LM; Oliva-Moreno J; Fernández-Rodriguez C
Eur J Health Econ; 2023 Nov; 24(8):1271-1283. PubMed ID: 36352296
[TBL] [Abstract][Full Text] [Related]
20. Cost of disorders of the brain in Europe 2010.
Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
